-
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
25 Apr 2024 11:21 GMT
… trial of investigational product candidate ADX-2191 (methotrexate injection … the FDA for treatment, a safe and effective drug that … Therapeutics is a biotechnology company devoted to … approach is to develop pharmaceuticals that modulate protein systems …
-
US Central and European Commands Should Revisit Disallowance of Systemic Treatments for Deployed Individuals With Psoriasis, Eczema, Paper Argues
24 Apr 2024 15:39 GMT
… filtering for clinical trials, randomized controlled trials, and meta- … in Systemic Medications
Traditionally, systemic medications for eczema and … treatment approaches.
For eczema, traditional immunosuppressants such as corticosteroids and methotrexate …
-
Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment
24 Apr 2024 07:54 GMT
… were purchased from SPF Biotechnology Co. Ltd. (Beijing … University of Traditional Chinese Medicine” (Chengdu, China … methotrexate prodrug self-assembling nanoparticles for enhancing intracellular drug … nanoparticles for the treatment of hepatocellular carcinoma …
-
Rituxan for the Treatment of Non-Hodgkin’s Lymphoma, US
23 Apr 2024 17:29 GMT
… ) is a prescription medicine indicated to treat blood … Pharmaceutical. In Roche’s pipeline, Rituxan is the second largest-selling drug … trial.
The FDA approved Rituxan as a maintenance treatment … studies.
The FDA approved Rituxan with methotrexate (MTX) for …
-
Dermatology Skills for Internal Medicine Physicians with Roy Colven, MD
20 Apr 2024 18:48 GMT
… systemic acne treatments, itch relief treatments beyond diphenhydramine, and methotrexate. Methotrexate specifically … at the ACP Internal Medicine Meeting provided several potentially … -invaluable insights for internal medicine physicians looking to expand …
-
Takeda's vedolizumab receives US FDA approval to treat moderately to severely active Crohn's disease
20 Apr 2024 10:39 GMT
… US FDA in September 2023 for the maintenance treatment … double-blind, placebo-controlled trial, which assessed the safety … Ritter, MD, senior medical director, Department of Research … (azathioprine, 6-mercaptopurine, or methotrexate), or tumor necrosis factor …
-
Understanding Zerodol SP: Its Ingredients and How They Work Together
22 Apr 2024 16:54 GMT
… steroidal anti-inflammatory drugs (NSAIDs). It … medication and medical condition with your doctor before … medications, oral antidiabetics, chemotherapy and immunosuppressants (methotrexate and ciclosporin), diuretics, anticoagulants (warfarin), medications …
-
Crohn’s Disease With an Active Flare of Systemic Lupus Erythematosus
19 Apr 2024 20:11 GMT
… The patient’s current medication regimen consists of Stelara … Previous medications, including Humira, Remicade, Entyvio, mesalamine, sulfasalazine, imuran, and methotrexate, … failure of multiple medications, further suggestions for treatment options are …
-
Epidemiology, Microbiology, and Risk Factors of Bacterial Bloodstream Infections in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
20 Apr 2024 07:43 GMT
… Tacrolimus (FK506) in combination with Methotrexate (MTX) and Mycophenolate mofetil ( … and the drugs could be considered a good treatment choice as … Society of Hematology, Chinese Medical Association; Chinese Medical Doctor Association, Hematology Branch. …
-
Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis
25 Apr 2024 12:21 GMT
… company developing new medicines for rare inflammatory … -controlled despite currently available treatment options.
“People living … immunosuppressive therapies (e.g., methotrexate) are first- and … participants across multiple clinical trials. Evidence from non …